Trial Profile
Phase II, Multi-Center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 21 Oct 2014
Price :
$35
*
At a glance
- Drugs Malathion (Primary)
- Indications Pediculosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 21 Oct 2014 New trial record